Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma
/in Hyperthermia, International Publications, Malignant Pleural Mesothelioma, NSCLC /von 2003-03-01 / Lung Cancer 2003 Mar;39(3):339-45In vivo induction of dendritic cell-mediated cytotoxicity against allogeneic pancreatic carcinoma cells
/in International Publications, Pancreatic Cancer /von 2003-03-01 / Int. J. Oncol. 2003 Mar;22(3):651-6Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive tract
/in Colorectal Cancer, International Publications /von 2003-03-01 / World J. Gastroenterol. 2003 Mar;9(3):495-8[Immune response of dendritic cells acquiring antigens from apoptotic cholangiocarcinoma cells induced by mitomycin]
/in Gallbladder Cancer, International Publications /von 2003-03-01 / Zhonghua Gan Zang Bing Za Zhi 2003 Mar;11(3):149-52
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution